On the contrary, PPARγ ligands have been shown to promote differentiation and apoptosis in a variety of cancer cells including colon cancer [39], prostate cancer, gastric cancer [40], bladder cancer [41], breast cancer [42]. Here, PPARG is linked to urinary bladder carcinoma.